Simulations of pertussis epidemiology in the United States: Effects of adult booster vaccinations

Mathematical Biosciences

Volumn 158, Issue 1, 1999, Pages 47-73

  Hethcote, Herbert W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Models; Pertussis; Simulations; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; DIPHTHERIA TETANUS VACCINE; PERTUSSIS VACCINE;

ADULT; ARTICLE; BACTERIAL IMMUNITY; COMPUTER SIMULATION; COST EFFECTIVENESS ANALYSIS; HUMAN; IMMUNOLOGICAL MEMORY; INCIDENCE; MATHEMATICAL MODEL; PERTUSSIS; UNITED STATES; VACCINATION;

ADULT; AGE FACTORS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNITY; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; UNITED STATES; VACCINATION; WHOOPING COUGH;

BACTERIA (MICROORGANISMS);

EID: 0032907094     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(99)00004-8     Document Type: Article

References (34)

1. A.S. Benenson, Control of Communicable Diseases in Man, 16th ed., American Public Health Association, Washington, DC, 1995.
2. J.E. Gordon, R.I. Hood, Whooping cough and its epidemiological anomalies, Am. J. Med. Sci. 222 (1951) 333.
3. J.D. Cherry, L.J. Baraff, E. Hewlett, The past, present and future of pertussis, West. J. Med. 150 (1989) 319.
4. Centers for Disease Control and Prevention, Tables I and III: Provisional cases of selected notifiable diseases, United States, MMWR 46 (1998) 1262.
5. C.A.M. Mink, J.D. Cherry, P. Christenson et al., A search for Bordetella pertussis infection in university students, Clin. Infect. Dis. 14 (1992) 464.
6. C.H.W, von Konig, S. Postels-Multani, H.L. Bock et al., Pertussis in adults: frequency of transmission after household exposure, Lancet 346 (1995) 1326.
7. S. Schmitt-Grohe, J.D. Cherry, U. Heininger et al., Pertussis in German adults, Clin. Infect. Dis. 21 (1995) 860.
8. S.W. Wright, K.M. Edwards, M.D. Decker et al., Pertussis infection in adults with persistent cough, JAMA 273 (1995) 1044.
9. R.J. Biellik, P.A. Patriarca, J.R. Mullen, et al., Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin, J. Infect. Dis. 157 (1988) 1134.
10. J.D. Nelson, The changing epidemiology of pertussis in young infants, Am. J. Dis. Child. 132 (1978) 371.
11. K.M. Farizo, S.L. Cochi, E.R. Zell et al., Epidemiological features of pertussis in the United States, 1980-1989, Clin. Infect. Dis. 14 (1992) 708.
12. E.A. Mortimer, Pertussis and pertussis vaccines: 15 years of change, Sem. Pediatr. Infect. Dis. 2 (1991) 82.
13. Centers for Disease Control and Prevention, Transmission of pertussis from adult to infant -Michigan, 1993, MMWR 44 (1995) 74.
14. Q. He, M.K. Viljanen, S. Nikkari et al., Outcomes of Bordetella pertussis infection in different age groups of an immunized population, J. Infect. Dis. 170 (1994) 873.
15. J.L. Deen, C.A.M. Mink, J.D. Cherry et al., Household contact study of Bordetella pertussis infections, Clin. Infect. Dis. 21 (1995) 1211.
16. J.G. Deville, J.D. Cherry, P.D. Christenson et al., Frequency of unrecognized Bordetella pertussis infections in adults, Clin. Infect. Dis. 21 (1995) 639.
17. L.A. Herwaldt, Pertussis in adults: What physicians need to know, Arch. Intern. Med. 109 (1991) 1510.
18. M.D. Greco, D. Salmaso, P. Mastrantonio et al., A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis, N. Engl. J. Med. 334 (1996) 341.
19. B. Trollfors, J. Taranger, T. Lagergard et al., A placebo-controlled trial of a pertussis-toxoid vaccine, N. Engl. J. Med. 333 (1995) 1045.
20. L. Gustafsson, H.O. Hallander, P. Olin et al., A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine, N. Engl. J. Med. 334 (1996) 349.
21. Centers for Disease Control and Prevention, Recommended childhood immunization schedule - United States, 1998, MMWR 47 (1998) 8.
22. K.M. Edwards, M.D. Decker, B.S. Graham et al., Adult immunization with acellular pertussis vaccine, JAMA 269 (1993) 53.
23. J.D. Cherry, Acellular pertussis vaccines: a solution to the pertussis problem, J. Infect. Dis. 168 (1993) 21.
24. K. Fackelmann, 100-day cough, Science News 150 (1996) 46.
25. M.E. Nennig et al., Prevalence and incidence of adult pertussis in an urban population, JAMA 275 (1996) 1672.
26. Centers for Disease Control and Prevention, Resurgence of pertussis - United States, 1993, MMWR 42 (1993) 952.
27. Centers for Disease Control and Prevention, Pertussis - United States, January 1992-June 1995, MMWR 44 (1995) 526.
28. Centers for Disease Control and Prevention, Table II: Cases of selected notifiable diseases, United States, MMWR 45 (1996) 23.
29. H.W. Hethcote, An age-structured model for pertussis transmission, Math. Biosci. 145 (1997) 89.
30. H.W. Hethcote, Oscillations in an endemic model for pertussis, Can. Appl. Math. Quart. 6 (1998) 61.
31. R.M. Anderson, R.M. May, Infectious Diseases of Humans: Dynamics and Control, Oxford University, Oxford, 1991.
32. Centers for Disease Control and Prevention, Pertussis surveillance - United States, 1989-1991, in: CDC Surveillance Summaries, 11 December 1992. MMWR 41 (No.SS-8) (1992) 11.
33. R.W. Sutter, S.L. Cochi, Pertussis hospitalizations and mortality in the United States, 1985-1988: Evaluation of the completeness of national reporting, JAMA 267 (1992) 386.
34. R.A. Strikas, Current vaccination levels in adults: The influenza and pneumococcal vaccines and tetanus toxoid, in: 29th National Immunization Conference Proceedings, Centers for Disease Control, 1995, p. 67.